Thomas Zimmer
Corporate Officer/Principal at International Society for Pharmaceutical Engineering
Profile
Thomas Zimmer is a professional who currently holds the position of Vice President-European Operations at the International Society for Pharmaceutical Engineering since 2013.
He previously served as Chairman at Northern Data AG from 2015 to 2016.
Zimmer holds a doctorate degree from Fachhochschule Frankfurt Am Main.
Thomas Zimmer active positions
Companies | Position | Start |
---|---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | 2013-11-12 |
Former positions of Thomas Zimmer
Companies | Position | End |
---|---|---|
NORTHERN DATA AG | Chairman | 2016-08-29 |
Training of Thomas Zimmer
Fachhochschule Frankfurt Am Main | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NORTHERN DATA AG | Technology Services |
Private companies | 1 |
---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Thomas Zimmer